# Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

> **NCT02314351** · PHASE4 · COMPLETED · sponsor: **Kocaeli University** · enrollment: 148 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Metoclopramide 10 mg
- **DRUG:** Placebo
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT02314351
- **Lead sponsor:** Kocaeli University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314351, "Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02314351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*